Pharmacology Quiz: Nsaids
20 questions · exam conditions
0:00
NsaidsQuestion 1 of 20

A patient taking daily low-dose aspirin for cardioprotection requires intermittent analgesia for headaches. They are advised to avoid concurrent ibuprofen use. What is the fundamental pharmacodynamic difference between aspirin and ibuprofen that underlies this recommendation?

Ibuprofen is a selective COX-2 inhibitor, while aspirin is non-selective.
Aspirin causes irreversible acetylation of platelet COX-1, while ibuprofen is a reversible, competitive inhibitor.
Aspirin has a much shorter plasma half-life than ibuprofen, leading to a less sustained clinical effect on platelets.
Ibuprofen is primarily metabolized by the kidneys, whereas aspirin is metabolized by the liver.
← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Nsaids

Practice Nsaids in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Nsaids, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient taking daily low-dose aspirin for cardioprotection requires intermittent analgesia for headaches. They are advised to avoid concurrent ibuprofen use. What is the fundamental pharmacodynamic difference between aspirin and ibuprofen that underlies this recommendation?

  1. Ibuprofen is a selective COX-2 inhibitor, while aspirin is non-selective.
  2. Aspirin causes irreversible acetylation of platelet COX-1, while ibuprofen is a reversible, competitive inhibitor. (correct answer)
  3. Aspirin has a much shorter plasma half-life than ibuprofen, leading to a less sustained clinical effect on platelets.
  4. Ibuprofen is primarily metabolized by the kidneys, whereas aspirin is metabolized by the liver.
Explanation: The key difference is the nature of COX-1 inhibition. Aspirin forms a covalent bond, irreversibly acetylating the serine residue in the active site of platelet COX-1. This effect lasts for the life of the platelet (7-10 days). Ibuprofen binds reversibly and competitively to the same site. If ibuprofen is present, it can block aspirin's access, preventing the irreversible inhibition required for sustained cardioprotection.

Question 2

A patient with chronic osteoarthritis is being counseled on strategies to reduce the gastrointestinal toxicity of long-term NSAID therapy. Which statement accurately describes a physiological mechanism relevant to this counseling?

  1. Selective COX-2 inhibitors eliminate GI risk by preserving all protective prostaglandin synthesis in the stomach lining.
  2. Thromboxane A2 (TXA2) is the main prostaglandin responsible for reducing gastric acid secretion and protecting the mucosa.
  3. Prostaglandin E2 (PGE2), synthesized via COX-1, is a primary mediator of gastric mucosal defense by stimulating mucus and bicarbonate secretion. (correct answer)
  4. Co-administration of an H2 receptor antagonist is the most effective method for preventing NSAID-induced gastric ulcers.
Explanation: The gastroprotective effects of prostaglandins are primarily mediated by the COX-1 isoform. Prostaglandin E2 (PGE2) and prostacyclin (PGI2) increase the secretion of protective mucus and bicarbonate, increase mucosal blood flow, and inhibit gastric acid secretion. Inhibition of COX-1 by non-selective NSAIDs removes these protective mechanisms, leading to GI toxicity.

Question 3

Under normal physiologic conditions in a healthy, euvolemic individual, a standard dose of an NSAID has minimal effect on GFR. However, in a patient with decompensated cirrhosis and ascites, the same dose can precipitate acute kidney injury. This difference is primarily because prostaglandins play a critical role in:

  1. maintaining afferent arteriolar dilation to preserve renal perfusion in states of high RAAS activation. (correct answer)
  2. mediating the natriuretic effect of diuretics used to manage ascites.
  3. promoting the renal tubular secretion of creatinine, leading to a falsely elevated GFR.
  4. directly inhibiting the vasoconstrictive effects of vasopressin on the efferent arteriole.
Explanation: In states of effective volume depletion such as decompensated cirrhosis, the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system are highly activated, causing systemic and renal vasoconstriction to maintain blood pressure. To preserve renal blood flow, the kidneys synthesize vasodilatory prostaglandins (PGE2, PGI2) that dilate the afferent arteriole. NSAIDs block this crucial compensatory mechanism, leading to unopposed afferent vasoconstriction, decreased renal perfusion, and a drop in GFR.

Question 4

A 70-year-old male is on stable, long-term warfarin therapy for atrial fibrillation, with a target INR of 2.0-3.0. He starts taking over-the-counter naproxen for arthritis pain. Which of the following represents the most significant combined risk of this drug combination?

  1. A pharmacokinetic interaction where naproxen displaces warfarin from albumin, leading to a dangerously high INR.
  2. A pharmacodynamic interaction significantly increasing the risk of major gastrointestinal bleeding. (correct answer)
  3. Naproxen directly antagonizing the anticoagulant effect of warfarin, leading to a subtherapeutic INR.
  4. Competitive inhibition of hepatic enzymes by naproxen, leading to toxic accumulation of warfarin metabolites.
Explanation: The most critical risk is a pharmacodynamic interaction. NSAIDs cause direct gastric mucosal injury and inhibit platelet aggregation (a COX-1 mediated effect). Warfarin inhibits the synthesis of vitamin K-dependent clotting factors. The combination of impaired platelet plug formation, compromised mucosal integrity, and impaired coagulation cascade creates a synergistic and extremely high risk of severe gastrointestinal bleeding, even if the INR remains in the therapeutic range.

Question 5

A 62-year-old male with a history of myocardial infarction 2 years ago has severe osteoarthritis of the knees. His physician is considering prescribing celecoxib to minimize GI side effects. Which statement best explains the primary cardiovascular concern with using a selective COX-2 inhibitor in this patient?

  1. Selective inhibition of COX-2 decreases prostacyclin (PGI2) production without affecting COX-1-mediated thromboxane A2 (TXA2) synthesis, creating a prothrombotic state. (correct answer)
  2. Selective COX-2 inhibitors cause significant sodium and water retention, which can acutely precipitate decompensated heart failure.
  3. Inhibition of COX-2 in the vascular endothelium leads to profound vasoconstriction and subsequent uncontrolled hypertension.
  4. Selective COX-2 inhibitors directly antagonize the antiplatelet effects of aspirin, rendering it ineffective for cardioprotection.
Explanation: The primary concern is the creation of a prothrombotic state. Platelets produce thromboxane A2 (TXA2) via COX-1, which promotes platelet aggregation and vasoconstriction. Vascular endothelial cells produce prostacyclin (PGI2) via COX-2, which inhibits platelet aggregation and causes vasodilation. By selectively inhibiting COX-2, celecoxib reduces PGI2, leaving the prothrombotic effects of TXA2 unopposed, thereby increasing the risk of cardiovascular events like MI and stroke.

Question 6

A 50-year-old patient develops fever, rash, and eosinophilia two weeks after starting a high-dose regimen of diclofenac for back pain. Urinalysis reveals white blood cell casts and eosinophiluria, and serum creatinine is elevated. Which of the following terms best describes this NSAID-induced renal pathology?

  1. Prerenal azotemia
  2. Analgesic nephropathy
  3. Acute interstitial nephritis (correct answer)
  4. Membranous glomerulonephritis
Explanation: This clinical presentation—fever, rash, eosinophilia, and renal failure with an active urinary sediment (WBC casts, eosinophiluria)—is the classic picture of acute interstitial nephritis (AIN). AIN is a cell-mediated hypersensitivity reaction affecting the renal interstitium and tubules. NSAIDs are a well-known cause of drug-induced AIN.

Question 7

A 45-year-old female with a history of chronic rhinosinusitis with nasal polyps and persistent asthma reports severe bronchospasm and urticaria minutes after taking a single dose of aspirin. She presents today with acute musculoskeletal pain. Which of the following medications is absolutely contraindicated in this patient?

  1. Acetaminophen
  2. Tramadol
  3. Ketoprofen (correct answer)
  4. Celecoxib
Explanation: This patient's presentation is classic for aspirin-exacerbated respiratory disease (AERD), or Samter's triad. The underlying mechanism involves shunting of arachidonic acid metabolism towards the leukotriene pathway upon COX-1 inhibition. This cross-reactivity applies to aspirin and all other non-selective NSAIDs. Therefore, ketoprofen, a non-selective NSAID, is absolutely contraindicated. Acetaminophen and tramadol are generally safe, and while caution is urged with celecoxib, it is not considered an absolute contraindication.

Question 8

A 40-year-old male undergoes orthopedic surgery and is prescribed intravenous ketorolac for post-operative pain. His pre-operative serum creatinine was 1.0 mg/dL. On post-op day 4, his creatinine is 1.8 mg/dL and his urine output is low. The patient has received ketorolac every 6 hours since surgery. What is the most likely contributing factor to his renal dysfunction?

  1. A hypersensitivity-mediated acute interstitial nephritis.
  2. An unforeseen pharmacokinetic interaction with anesthetic agents.
  3. Development of tolerance to the analgesic effects, leading to nephrotoxic metabolite accumulation.
  4. Exceeding the recommended maximum duration of therapy, which is limited due to high risk of severe adverse effects. (correct answer)
Explanation: Ketorolac carries a black box warning for significant renal and GI toxicity. Due to these risks, the total combined duration of therapy (parenteral and oral) is strictly limited to a maximum of 5 days. The post-operative state is already a risk factor for renal hypoperfusion. Using ketorolac for 4 days in this setting makes dose- and duration-dependent toxicity the most probable cause of his acute kidney injury.

Question 9

A 66-year-old female with hypertension, well-controlled on ramipril and hydrochlorothiazide, begins taking over-the-counter naproxen for knee pain. During a follow-up visit one month later, her blood pressure is elevated from her baseline of 125/75 mmHg to 150/90 mmHg. The addition of naproxen is most likely antagonizing the effects of her antihypertensive medications by which mechanism?

  1. Upregulating the expression of beta-1 adrenergic receptors in the heart.
  2. Inducing the metabolism of hydrochlorothiazide via cytochrome P450 enzymes.
  3. Inhibiting the synthesis of renal prostaglandins, leading to increased sodium and water reabsorption. (correct answer)
  4. Competing with ramipril for binding sites on the angiotensin-converting enzyme.
Explanation: Renal prostaglandins have a natriuretic and diuretic effect, contributing to sodium and water balance. By inhibiting prostaglandin synthesis, NSAIDs promote sodium and water retention. This effect counteracts the therapeutic actions of many antihypertensive agents, particularly diuretics (like hydrochlorothiazide) and ACE inhibitors (like ramipril), leading to an increase in blood pressure.

Question 10

A 68-year-old female with rheumatoid arthritis and a history of a bleeding peptic ulcer 1 year ago requires an anti-inflammatory agent. Her current medications include methotrexate. Which of the following is the most appropriate management strategy to minimize her risk of a recurrent GI bleed?

  1. Initiate naproxen with an H2 receptor antagonist.
  2. Recommend ibuprofen taken with meals and misoprostol.
  3. Start low-dose ketorolac for the shortest possible duration.
  4. Prescribe celecoxib and co-administer a proton pump inhibitor. (correct answer)
Explanation: The patient is at high risk for a recurrent GI bleed. The best strategy combines a COX-2 selective inhibitor (celecoxib), which spares the gastroprotective COX-1 enzyme, with a proton pump inhibitor (PPI), which is the most effective agent for preventing NSAID-induced ulcers. This combination offers the lowest risk of GI complications.

Question 11

A 75-year-old male with stable congestive heart failure (ejection fraction 30%) and hypertension is managed with lisinopril and furosemide. He is started on ibuprofen 600 mg three times daily for osteoarthritis pain. One week later, his serum creatinine increases from 1.2 mg/dL to 2.5 mg/dL. What is the most likely mechanism for this acute kidney injury?

  1. Drug-induced hypersensitivity reaction causing acute interstitial nephritis.
  2. Inhibition of prostaglandin-mediated afferent arteriolar vasodilation. (correct answer)
  3. Blockade of angiotensin II-mediated efferent arteriolar vasoconstriction.
  4. Direct nephrotoxic effect causing acute tubular necrosis.
Explanation: In states of decreased effective circulating volume like heart failure, renal blood flow is highly dependent on prostaglandins (PGE2, PGI2) to vasodilate the afferent arteriole. NSAIDs inhibit prostaglandin synthesis, leading to unopposed vasoconstriction of the afferent arteriole, a decrease in glomerular filtration pressure, and subsequent acute kidney injury. This risk is magnified by concurrent ACE inhibitor use, which dilates the efferent arteriole.

Question 12

A 62-year-old male with a history of myocardial infarction 2 years ago has severe osteoarthritis of the knees. His physician is considering prescribing celecoxib to minimize GI side effects. Which statement best explains the primary cardiovascular concern with using a selective COX-2 inhibitor in this patient?

  1. Selective inhibition of COX-2 decreases prostacyclin (PGI2) production without affecting COX-1-mediated thromboxane A2 (TXA2) synthesis, creating a prothrombotic state. (correct answer)
  2. Selective COX-2 inhibitors cause significant sodium and water retention, which can acutely precipitate decompensated heart failure.
  3. Inhibition of COX-2 in the vascular endothelium leads to profound vasoconstriction and subsequent uncontrolled hypertension.
  4. Selective COX-2 inhibitors directly antagonize the antiplatelet effects of aspirin, rendering it ineffective for cardioprotection.
Explanation: The primary concern is the creation of a prothrombotic state. Platelets produce thromboxane A2 (TXA2) via COX-1, which promotes platelet aggregation and vasoconstriction. Vascular endothelial cells produce prostacyclin (PGI2) via COX-2, which inhibits platelet aggregation and causes vasodilation. By selectively inhibiting COX-2, celecoxib reduces PGI2, leaving the prothrombotic effects of TXA2 unopposed, thereby increasing the risk of cardiovascular events like MI and stroke.

Question 13

A 66-year-old female with hypertension, well-controlled on ramipril and hydrochlorothiazide, begins taking over-the-counter naproxen for knee pain. During a follow-up visit one month later, her blood pressure is elevated from her baseline of 125/75 mmHg to 150/90 mmHg. The addition of naproxen is most likely antagonizing the effects of her antihypertensive medications by which mechanism?

  1. Upregulating the expression of beta-1 adrenergic receptors in the heart.
  2. Inducing the metabolism of hydrochlorothiazide via cytochrome P450 enzymes.
  3. Inhibiting the synthesis of renal prostaglandins, leading to increased sodium and water reabsorption. (correct answer)
  4. Competing with ramipril for binding sites on the angiotensin-converting enzyme.
Explanation: Renal prostaglandins have a natriuretic and diuretic effect, contributing to sodium and water balance. By inhibiting prostaglandin synthesis, NSAIDs promote sodium and water retention. This effect counteracts the therapeutic actions of many antihypertensive agents, particularly diuretics (like hydrochlorothiazide) and ACE inhibitors (like ramipril), leading to an increase in blood pressure.

Question 14

A patient with chronic osteoarthritis is being counseled on strategies to reduce the gastrointestinal toxicity of long-term NSAID therapy. Which statement accurately describes a physiological mechanism relevant to this counseling?

  1. Selective COX-2 inhibitors eliminate GI risk by preserving all protective prostaglandin synthesis in the stomach lining.
  2. Thromboxane A2 (TXA2) is the main prostaglandin responsible for reducing gastric acid secretion and protecting the mucosa.
  3. Prostaglandin E2 (PGE2), synthesized via COX-1, is a primary mediator of gastric mucosal defense by stimulating mucus and bicarbonate secretion. (correct answer)
  4. Co-administration of an H2 receptor antagonist is the most effective method for preventing NSAID-induced gastric ulcers.
Explanation: The gastroprotective effects of prostaglandins are primarily mediated by the COX-1 isoform. Prostaglandin E2 (PGE2) and prostacyclin (PGI2) increase the secretion of protective mucus and bicarbonate, increase mucosal blood flow, and inhibit gastric acid secretion. Inhibition of COX-1 by non-selective NSAIDs removes these protective mechanisms, leading to GI toxicity.

Question 15

A patient taking daily low-dose aspirin for cardioprotection requires intermittent analgesia for headaches. They are advised to avoid concurrent ibuprofen use. What is the fundamental pharmacodynamic difference between aspirin and ibuprofen that underlies this recommendation?

  1. Ibuprofen is a selective COX-2 inhibitor, while aspirin is non-selective.
  2. Aspirin causes irreversible acetylation of platelet COX-1, while ibuprofen is a reversible, competitive inhibitor. (correct answer)
  3. Aspirin has a much shorter plasma half-life than ibuprofen, leading to a less sustained clinical effect on platelets.
  4. Ibuprofen is primarily metabolized by the kidneys, whereas aspirin is metabolized by the liver.
Explanation: The key difference is the nature of COX-1 inhibition. Aspirin forms a covalent bond, irreversibly acetylating the serine residue in the active site of platelet COX-1. This effect lasts for the life of the platelet (7-10 days). Ibuprofen binds reversibly and competitively to the same site. If ibuprofen is present, it can block aspirin's access, preventing the irreversible inhibition required for sustained cardioprotection.

Question 16

A 50-year-old patient develops fever, rash, and eosinophilia two weeks after starting a high-dose regimen of diclofenac for back pain. Urinalysis reveals white blood cell casts and eosinophiluria, and serum creatinine is elevated. Which of the following terms best describes this NSAID-induced renal pathology?

  1. Prerenal azotemia
  2. Analgesic nephropathy
  3. Acute interstitial nephritis (correct answer)
  4. Membranous glomerulonephritis
Explanation: This clinical presentation—fever, rash, eosinophilia, and renal failure with an active urinary sediment (WBC casts, eosinophiluria)—is the classic picture of acute interstitial nephritis (AIN). AIN is a cell-mediated hypersensitivity reaction affecting the renal interstitium and tubules. NSAIDs are a well-known cause of drug-induced AIN.

Question 17

A 70-year-old male is on stable, long-term warfarin therapy for atrial fibrillation, with a target INR of 2.0-3.0. He starts taking over-the-counter naproxen for arthritis pain. Which of the following represents the most significant combined risk of this drug combination?

  1. A pharmacokinetic interaction where naproxen displaces warfarin from albumin, leading to a dangerously high INR.
  2. A pharmacodynamic interaction significantly increasing the risk of major gastrointestinal bleeding. (correct answer)
  3. Naproxen directly antagonizing the anticoagulant effect of warfarin, leading to a subtherapeutic INR.
  4. Competitive inhibition of hepatic enzymes by naproxen, leading to toxic accumulation of warfarin metabolites.
Explanation: The most critical risk is a pharmacodynamic interaction. NSAIDs cause direct gastric mucosal injury and inhibit platelet aggregation (a COX-1 mediated effect). Warfarin inhibits the synthesis of vitamin K-dependent clotting factors. The combination of impaired platelet plug formation, compromised mucosal integrity, and impaired coagulation cascade creates a synergistic and extremely high risk of severe gastrointestinal bleeding, even if the INR remains in the therapeutic range.

Question 18

An 8-year-old child is recovering from an influenza infection. The parents administered an over-the-counter medication for fever and aches. Several days later, the child develops persistent vomiting, lethargy, and confusion. Laboratory tests show elevated aminotransferases, hyperammonemia, and a prolonged prothrombin time. The use of which medication is most likely associated with this clinical presentation?

  1. Ibuprofen
  2. Acetaminophen
  3. Aspirin (correct answer)
  4. Naproxen
Explanation: This clinical vignette describes Reye's syndrome, a rare but serious condition characterized by acute encephalopathy and fatty liver failure. There is a strong epidemiological association between the use of aspirin (a salicylate) for fever in children and adolescents during a viral illness (especially influenza or varicella) and the development of Reye's syndrome. For this reason, aspirin is contraindicated in this population.

Question 19

A pharmaceutical company is developing a new NSAID. Preclinical studies show that it has an IC50 for COX-1 of 50 µM and an IC50 for COX-2 of 0.5 µM. Based on this profile, which of the following is most likely to be true regarding the drug's effects at therapeutic concentrations?

  1. It will have a lower propensity to cause gastric mucosal damage compared to a non-selective NSAID. (correct answer)
  2. It will effectively inhibit platelet aggregation at therapeutic doses.
  3. It will be associated with a reduced risk of thrombotic cardiovascular events.
  4. It will provide analgesia but will lack significant anti-inflammatory activity.
Explanation: The ratio of IC50 (COX-1/COX-2) is 50/0.5 = 100, indicating that the drug is 100 times more potent at inhibiting COX-2 than COX-1. This profile is characteristic of a selective COX-2 inhibitor. By preferentially inhibiting COX-2 and sparing COX-1 at therapeutic doses, the drug will preserve the synthesis of COX-1-derived protective prostaglandins in the gastric mucosa, leading to a lower risk of GI toxicity compared to non-selective agents like ibuprofen or naproxen.

Question 20

A patient with a history of gastritis asks if switching from their prescribed naproxen to over-the-counter ibuprofen would be safer for their stomach. Which statement provides the most accurate information to this patient?

  1. Ibuprofen is much safer for the stomach because it is a selective COX-2 inhibitor, which spares the gastric lining.
  2. Naproxen has a longer half-life, which makes it inherently more damaging to the gastric mucosa than the shorter-acting ibuprofen.
  3. Both naproxen and ibuprofen are non-selective NSAIDs that carry a significant risk of GI toxicity; switching is unlikely to provide a meaningful reduction in risk. (correct answer)
  4. Enteric-coated formulations of either drug completely eliminate the risk of gastric ulceration by preventing direct local irritation.
Explanation: This addresses a common patient misconception. Both ibuprofen and naproxen are traditional, non-selective NSAIDs that inhibit both COX-1 and COX-2. While population studies may show slight differences in relative risk, for an individual patient at risk for GI toxicity, both carry a significant risk. Switching between them is not a recognized strategy for meaningfully improving gastric safety. The primary mechanism of injury is systemic prostaglandin inhibition, not just local irritation.